Hans-Gustaf Ljunggren

20PUBLICATIONS
81CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Biologically active moleculesInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 13, 2025
Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration.

Yulin Li, Zhiguo Li, Pei Zheng

|Aug 12, 2025
Both inhibitory and activating KIRs recognize RIFINs: a dual-edged mechanism of NK cell control in malaria.

Angelica Cuapio, Hans-Gustaf Ljunggren

|Dec 20, 2023
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.

Tobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot

|Mar 14, 2023
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age.

Marion Humbert, Anna Olofsson, David Wullimann

Pageof 4